Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
N-(4-Phenylpiperidin-4-yl)acetamide → 5-[(1RS,2RS)-2-(3,4-Dichlorophenyl)-1-hydroxy-4-(4-acetamido-4-phenylpiperidino)butyl]-1-phenylpyrazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | N-(4-Phenylpiperidin-4-yl)acetamide | HCID 15886675 | — |
| 반응물 | 5-[(1RS,2RS)-1-acetoxy-2-(3,4-dichlorophenyl)-4-oxobutyl]-1-phenylpyrazole | HCID 18930277 | — |
| 반응물 | 5-[(1RS,2RS)-1-Acetoxy-2-(3,4-dichlorophenyl)-4-(4-acetamido-4-phenylpiperidino)butyl]-1-phenylpyrazole | HCID 18930280 | — |
| 생성물 | 5-[(1RS,2RS)-2-(3,4-Dichlorophenyl)-1-hydroxy-4-(4-acetamido-4-phenylpiperidino)butyl]-1-phenylpyrazole | HCID 18930310 | — |
반응 단계
5-[(1RS,2RS)-1-Acetoxy-2-(3,4-dichlorophenyl)-4-(4-acetamido-4-phenylpiperidino)butyl]-1-phenylpyrazole. Using a procedure similar to that described in Example 7, except using 4-acetamido-4-phenylpiperidine as the amine component and 5-[(1RS,2RS)-1-acetoxy-2-(3,4-dichlorophenyl)-4-oxobutyl]-1-phenylpyrazole as the aldehyde component, the title compound was obtained as a white foam (65%; NMR: 7.58 (d,1), 7.48-7.21 (m,11), 7.09 (d, 1), 6.81 (dd, 1), 6.22 (d, 1), 6.09 (d, 1), 5.39 (s,1), 3.06 (m,1), 2.51 (m,2), 2.31 (m,2), 2.15-2.00 (m,7), 1.98 (s,3), 1.96 (s,3), 1.75 (m,1), 1.43 (m,1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05635509 |
| 출처 데이터셋 | uspto-grants-1997_06 |
| ORD ID | ord-fb5a0f949ba840478c93d3ae0ba630dc |
| 출처 메모 | uspto-grants-1997_06 |